Abstract
The present invention relates to novel inhibitors of the Energy Coupling Factor (ECF) Transporters. These compounds of general formula (I) are useful in the treatment of bacterial infections, especially caused by Streptococcus pneumoniae, Enterococcus faecium, Enterococcus faecalis.
| Original language | English |
|---|---|
| Patent number | WO2025104079 |
| Priority date | 17/11/2023 |
| Filing date | 13/11/2024 |
| Publication status | Published - 22-May-2025 |